Uranium Royalty Corp (NASDAQ: UROY) stock fell -0.34% on Monday to $2.95 against a previous-day closing price of $2.96. With 1.2 million shares changed hands, the volume of the stock remained lighter than its average volume of 1.41 million shares. The 52-week range on UROY shows that it touched its highest point at $3.29 and its lowest point at $1.81 during that stretch. It currently has a 1-year price target of $5.42. Beta for the stock currently stands at 1.70.
Price Performance and Earnings:
Stock performance is one of the indicators that investors use to determine whether they will profit from a stock. The price performance of UROY was up-trending over the past week, with a rise of 4.24%, but this was up by 6.88% over a month. Three-month performance surged to 26.07% while six-month performance rose 46.77%. The stock gained 9.67% in the past year, while it has gained 24.47% so far this year.
Float and Shares Shorts:
At present, 99.80 million UROY shares are outstanding with a float of 81.22 million shares on hand for trading. On Oct 30, 2023, short shares totaled 1.74 million, which was 1.72% higher than short shares on Sep 28, 2023. In addition to Mr. Scott Eric Melbye as the firm’s CEO, President & Director, Ms. Josephine Man serves as its Chief Financial Officer.
Institutional Ownership:
Through their ownership of 16.76% of UROY’s outstanding shares, institutional investors have minority control over the company. With a 4.54% stake in UROY, the Global X Uranium ETF is the largest stakeholder. A total of 4,592,902 shares are owned by the mutual fund manager. The Sprott Uranium Miners ETF, which owns about 4.31% of UROY stock, is the second-largest Mutual Fund holder. It holds 4,356,879 shares valued at 12.46 million. Sprott Junior Uranium Miners ETF holds 1.35% of the stake in UROY, owning 1,365,016 shares worth 3.9 million.
Analysts Ratings:
Reading analyst opinions is an effective way to decide where to invest, and there are several opinions available for UROY since 0 analysts follow the stock currently. In the same way, a target price assigned to a stock can also reveal much about its potential. With UROY analysts setting a high price target of $6.20 and a low target of $4.63, the average target price over the next 12 months is $5.42. Based on these targets, UROY could surge 110.17% to reach the target high and rise by 56.95% to reach the target low. Reaching the average price target will result in a growth of 83.73% from current levels.
